SAN ANTONIO – The U.S. Food and Drug Administration has granted Xenex Disinfection Services a De Novo authorization for its LightStrike+ device. That decision is expected to significantly drive up demand for the San Antonio-based company’s germ-zapping robots. The Xenex machines utilize high-intensity, broad-spectrum ultraviolet light to reduce potentially deadly…Read More
Related Posts
Telesis Bio Announces Closing of 280 Million Private Placement of Preferred Stock And Warrants to…
SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced the closing…
Anbio Biotechnology to Participate in the 2023 AACC Meeting
ANAHEIM, Calif., June 28, 2023 /PRNewswire/ -- Anbio Biotechnology (Anbio), a leading global diagnostic device and assay company, has announced its participation in the 2023 American Association for Clinical Chemistry…
Acumen Pharmaceuticals to Report Third Quarter Financial Results on November 13 2023
CHARLOTTESVILLE, VA. and INDIANAPOLIS, IN., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) ("Acumen" or the "Company"), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets…
